Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalpana M Devaraj

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|February 7, 2014
Clinical problem-solving. Missing elements of the historyLarry A Allen, Amrut V Ambardekar, Kalpana M Devaraj, et al.
Cancer Investigation|November 17, 2010
Obesity and microvascular invasion in hepatocellular carcinomaAbby B Siegel, Shuang Wang, Judith S Jacobson, et al.
Oncotarget|January 18, 2018
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapyJustin Greene, Anna Nguyen, Stacey M Bagby, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|February 7, 2014
Clinical problem-solving. Missing elements of the historyLarry A Allen, Amrut V Ambardekar, Kalpana M Devaraj, et al.
Cancer Investigation|November 17, 2010
Obesity and microvascular invasion in hepatocellular carcinomaAbby B Siegel, Shuang Wang, Judith S Jacobson, et al.
Oncotarget|January 18, 2018
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapyJustin Greene, Anna Nguyen, Stacey M Bagby, et al.
Pageof 1